Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Novaliq reports positive results from Phase II NOV03 trial

NOV03 is a preservative-free ophthalmic solution for DED. Credit: Business Wire.



  • NOV03

Go Top